+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Imaging Breast & Prostate Cancer - Technologies, Market Trends and Applications, 2021

  • Report
  • 80 Pages
  • December 2021
  • Region: Global
  • Tematys
  • ID: 5483338

Breast & Prostate cancers have always been in the news due to their widespread occurrence, nature, complexity and aggressiveness. They are the two most commonly found invasive cancers in women and men, respectively.


In the last couple of decades, the detection, localization and diagnosis of these cancers has seen tremendous advances thanks to technology and innovation in the field of Medical imaging, recently focusing on noninvasive optical techniques. Imaging is an important part of cancer clinical protocols and can provide a variety of information about morphology, structure, metabolism and bodily functions.


Biomedical imaging can thus be used in the prediction, staging, screening, prognosis, biopsy guidance for diagnosis, plan of treatment, therapy guidance, therapy response recurrence and palliation of these cancers. With increasing cancer risk globally, there is a higher need for screening and diagnosis as early as possible.


Key Features of the Report

  • Existing, New and Evolving Imaging approaches for detecting and treating Breast & Prostate Cancers 
  • Market revenue breakdown for the main Imaging modalities 
  • Market forecast of Imaging modalities from 2020-2026 
  • Presentation of dominant market trends 
  • Summary of ongoing clinical trials, funded projects, investments and M&A’s for cancer imaging.
  • Review of most promising upcoming systems/devices

Study Goals and Objectives

  • To provide a thorough analysis of the in vivo imaging modalities for breast and prostate cancer.
  • To summarize the global overview, prevalence, disease progression, trends, regulations and existing facilities for imaging breast and prostate cancer.
  • To detail and describe all the imaging technologies and its market segmentation.
  • To provide the product range, value chain, existing and upcoming market trends and forecast for imaging these cancers.
  • To analyse the technologies and strategies of the various actors and influencers in the value chain.

Table of Contents

1. INTRODUCTION
  • Study Goals and Objectives
  • Information sources and methodology
  • Scope of the report
  • Glossary
  • Definitions
  • List of companies mentioned in the report


2. BREAST & PROSTATE CANCER FACTS
  • Prevalence
  • Scanning & Surgeries


3. TECHNOLOGY SEGMENTATION
  • Existing Technologies
  • Imaging Techniques for Breast & Prostate Cancer
  • Breast Imaging
  • Prostate Imaging
  • Medical Expectations


4. MARKET DATA AND TRENDS
  • Market Segmentation
  • Overview of Key Imaging Systems’ manufacturers
  • Market and Forecast
  • Finance & Takeovers


5. NOTICEABLE UPCOMING R & D TECHNOLOGIES
  • Major centres/organisations for clinical trials
  • Funding/Projects
  • Patents’ Landscape
  • Major Trends


6. REGULATORY ASPECTS7. CONCLUSIONS8. ABOUT THE PUBLISHER

Companies Mentioned

  • AB-CT
  • Adani
  • AGFA Healthcare
  • Bio Medical International
  • Canon
  • CMR Naviscan,
  • DMS Imaging
  • Ecoray
  • Esaote
  • EXO
  • GE Healthcare
  • Genoray
  • Hologic
  • IMS Giotto,
  • Italray
  • Konica Minolta
  • Koning
  • Landwind Medical
  • Leica Biosystems
  • Lorad,
  • Metaltronica S.P.A.
  • Mindray
  • MS Westfalia
  • Panacea Engineering Medicine,
  • OncoVision
  • Philips
  • Planmed
  • Seno Medical
  • Siemens Healthineers
  • SIUI
  • Shimadzu,
  • Sternmed
  • Toshiba
  • Villa Sistemi Medicali S.P.A.